Clinical Trials Browser

Phase 2 × Multiple Myeloma × nirogacestat × Clear all

NCT05090566 2026-04-24

MagnetisMM-4: Umbrella Study of Elranatamab (PF-06863135) in Combination With Anti-Cancer Treatments in Multiple Myeloma

Phase 2 Terminated

46 enrolled 15 charts

Multiple Myeloma